Awak Technologies Raises Us$20+ Million, Readying Its Wearable Dialysis Device For Us-Based Pivotal Trial

Sep 13, 2023•almost 2 years ago

Amount Raised

$20 Million

SingaporeMedicalBiotechnologyHealth Care

Investors

Eckuity CapitalAdvanced Med TechVickers Venture PartnersLion X Ventures

Description

AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration technology for end-stage renal disease, today announced it has successfully raised US$20+ million in Series B funding. This milestone not only represents the most substantial MedTech fundraising event in Singapore for 2023, but also one of the largest in Southeast Asia this year. The round was co-led by Lion X Ventures and Vickers Venture Partners, both venture capital firms, with other key investors including Advanced MedTech, Eckuity Capital, a US-based healthcare venture capital fund, and an investment office with multibillion dollar assets under management in the healthcare sector.

Company Information

Company

AWAK Technologies

Location

Singapore, Southeast Asia, Singapore

About

AWAK Technologies Pte. Ltd. is a pioneering, patient-centric medical technology company with a mission to enhance the lives of people with kidney disease and their caregivers by providing solutions to deliver better outcomes and improve their quality of life. Headquartered in Singapore with offices in Burbank, California, USA and Bengaluru, India, the company is dedicated to the research, development and marketing of novel, sorbent-based kidney dialysis machine for the treatment of patients with end-stage renal disease. For more information, please visit: www.awak.com

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends